accumulation. IDPN appears to be effective in malnourished elderly haemodialysis patients. Background. The treatment of malnutrition, frequently present in elderly dialysis patients, is important to Key words: amino acids; elderly patients; haemodiapromote better quality of life and rehabilitation. The lysis; intradialysis parenteral nutrition; malnutrition aim of this study was to assess the impact of prolonged use of intradialysis parenteral nutrition (IDPN ) as a strategy for malnutrition in elderly haemodialysis patients.
Introduction
Methods. Twenty-eight elderly patients (non-diabetic, age over 70) on chronic haemodialysis for at least 2 Malnutrition, an important determinant of morbidity years were evaluated. Ten consenting patients were and mortality, is frequently encountered in young treated with IDPN containing glucose, essential amino patients, as well as in elderly patients receiving regular acids, and lipid emulsion during the course of regularly haemodialysis therapy [1] [2] [3] [4] [5] [6] . In view of the rapidly scheduled dialysis treatments for approximately 1 year.
expanding number of haemodialysis patients aged 70 Nutritional evaluation using seven parameters (anthroyears or older, the detection and treatment of malnutripometric measurements such as body mass index, tion in these patients is important to provide better triceps skinfold thickness, mid-arm circumference, midrehabilitation and quality of life, even though the arm muscle circumference, and albumin, transferrin, impact of end-stage renal disease on life expectancy and total lymphocyte count) was performed at various decreases with increasing age [7] . intervals on patients with IDPN and 18 patients withInadequate dialysis appears to result in impaired out IDPN. The plasma amino-acid profile and dietary appetite and decreased intake of meals. However, a protein calorie intake were also determined.
poorly positive relationship between dialysis efficacy Results. In patients receiving IDPN, significant and oral protein intake in elderly patients has been increases in serum albumin and transferrin concentraindicated in several reports including ours [8, 9] . One tions and total lymphocyte count in peripheral blood study indicated a lower protein catabolic rate, which smears paralleled increases in protein-calorie intake estimates oral protein intake in metabolically stable beginning after 3 months of treatment and remained patients, in elderly haemodialysis patients with favourable throughtout the study period. Anthroadequate and stable Kt/V urea [9] . pometric data started to improve significantly after There are many causes for malnutrition in elderly 6 months of treatment. Patients without IDPN had persons and once malnutrition develops, one cannot gradual decreases in all parameters during the study expect a rapid increase in oral nutrient intake and period. A significant increase in essential amino acids improvement of nutritional status. Eldery persons may and a significant decrease in 3-methyl-histidine were suffer a decline in the senses of smell and taste, dental observed in patients with IDPN and a further decrease problems which decrease the ability to chew certain in essential amino acids was observed in patients foods, and diminution of vision, all of which may without IDPN. make eating less pleasant [10] . Malabsorption of nutriConclusion. Prolonged use of IDPN prevents muscle ents may also result from a decrease in gastric acid protein catabolism and promotes body protein and fat secretion or from interactions with medications commonly prescribed for older persons [10]. treatment for malnutrition because of the possible presence of neurological and metabolic disorders mentioned above. The problem of compliance is also 
Patients and study protocol
Body-weight gain equalled the difference between the post-dialysis body-weight at the last haemodialysis session of a week and the Twenty-eight patients over age 70 undergoing maintenance predialysis body-weight at the first haemodialysis session of the haemodialysis for more than 2 years were evaluated. All following week.
patients were maintained on thrice-weekly chronic haemodia-PS, polysulphone; PMMA, polymethylmethacrylate; PEPA, polyaclysis treatment at the Dialysis Center of Chikuho Hospital rylate/polyethylsulphone; c-PTH, c-terminal parathyroid hormone; using bicarbonate as the buffer solution for approximately IDPN, intradialysis parenteral nutrition; n.s., not significant. 4 h at a time. Haemodialysers used during the whole experimental period included polysulphone (PS, Fresenius, Bad Homburg, FRG) sterilized by autoclave, polymethylmethac-IDPN consisting of 200 ml 50% dextrose, 200 ml 7.1% essenrylate (PMMA, Toray Medical, Tokyo, Japan) sterilized by tial amino acids (Amiyu, Morishita Co., Tokyo, Japan, gamma irradiation, and polyacrylate/polyethylsulphone Table 1) , and 200 ml 20% lipid emulsion (Intralipos, Green (PEPA, Nikkiso Co., Tokyo, Japan) sterilized by gamma Cross Co, Osaka, Japan). It provided 2400 kcal and 42.3 g irradiation. All patients were stable with no recent surgery, amino acids per week. The 18 patients not receiving IDPN and none had significant daily diuresis, systemic complica-received dietary counselling from a certified dietitian during tions such as malignancy or severe infection, or endocrinolog-the study period. Nutritional surveys were performed just ical disorders. None had diabetic nephropathy as a primary before the start of IDPN (control observation) and at 3, 6, renal disease. The following renal diet was prescribed to the and 12 months after the start of IDPN, and were compared patients before the start of this study. The recommended to surveys in the patients not given IDPN. None of the energy intake in our unit is 30-35 kcal/kg body-weight/day, patients had acute concomitant illness at the time of nutriwhereas that for protein is 1.0-1.2 g/kg body-weight/day. tional evaluation. No significant differences in the demoAll selected patients were unemployed and were hospitalized graphic characteristics between the two groups were for socioeconomic reasons. During the whole study period, apparent, except for age which was significantly higher for anaemia and hypertension were controlled using appropriate patients with IDPN (P=0.0089) ( Table 2) . recombinant human erythropoietin and antihypertensive Dialysis efficacy estimated by Kt/V urea was calculated agents, respectively. Written informed consent from patients twice a month using Daugirdas's equation, and never was obtained and the study was conducted in accordance changed during the study period in both groups [19] . with the principles of the Declaration of Helsinki.
Intravenous nutrient supply was recommended when malnutrition was ascertained at the first nutritional assessment Nutritional evaluation (control observation). Ten patients agreed to receive IDPN and 18 patients refused, possibly because of the increase in Dietary protein calorie intake was estimated for 7 consecutive days by a certified dietitian and the mean values were used. ultrafiltration volume. For 1 year during the course of their regularly scheduled dialysis treatments, patients received Just before the first dialysis session blood samples were Table 3 . Baseline nutritional parameters drawn for albumin (Alb), transferrin ( Tf ), total lymphocyte count (TLC ), and amino-acid concentrations.
Height and body dry weight (BDW, kg) were determined
and body mass index (BMI, kg/m2) was calculated using Parameters The plasma amino-acid profile was determined by fluores-total lymphocyte count. cence high-performance liquid chromatography in all patients before the study and at 6 and 12 months after the start of IDPN. The results were also compared to 21 healthy subjects over age 70.
vasculitis nor any other complications associated with fistulae occurred. Apparent change in dialysis efficacy secondary to interference with the dialysance of the Statistics artificial kidney membrane was not observed in patients The data are expressed as mean±standard deviation (SD) receiving IDPN. In patients receiving IDPN, a maxunless otherwise indicated. Student's t test for paired observa-imum glucose level of 214±38 mg/dl was observed at tions was used to evaluate the various nutritional parameters. the end of the dialysis session, and which fell below A two-way analysis of variance (ANOVA) was used to 120 mg/dl at 2 h. After 1 year of treatment, the fasting compare mean values between treated and untreated patients. the start and end of this study were 146±44 mg/dl ables was estimated by the Pearson product moment correlation coefficient with two-tailed probabilities. Differences were and 158±54, respectively (not significant, n.s.) and considered significant when P was less than 0.05. those of triglyceride were 89±31 mg/dl and 108±39, respectively (n.s.).
During the study period, all the patients receiving
Results
IDPN remaind alive while five patients without IDPN died (P<0.02 compared to patients with IDPN ).
Baseline nutritional evaluation
Causes of death included pneumonia and sepsis (3 patients), gastrointestinal bleeding (1 patient), and Table 3 summarizes the baseline nutritional data of the cachexia (1 patient). Two patients died at 7 months two groups. There were no significant differences after the start of this study, one at 8 months, and two between the two groups. A marked decrease in % at 11 months. standard TSF and a low calorie intake were demon-
The chronological data for all nutritional parastrated in both groups. Malnutrition was apparent in meters in patients with or without IDPN are shown both groups; however, patients receiving IDPN tended in Figures 1 and 2 . After 3 months of therapy with to be more malnourished although not significantly so.
IDPN, oral intake of protein and calories as well as Both groups received adequate dialysis with a mean albumin, transferrin, and total lymphocyte cell count Kt/V urea near 1.3. No significant correlations between significantly increased (Figure 2 ). These favourable time on haemodialysis or age and value of each nutrichanges persisted throughout the remaining study tional parameter were noted. None of the patients was period. However, a gradual decrease in these parawell nourished. meters was observed in patients without IDPN, resulting in significant decreases in those values at 12 Effect of IDPN on nutritional parameters months after the start of this study compared with values at baseline. The respective changes in anthropoDuring the entire experimental period, IDPN was well metric measurements became significant at later time tolerated in all patients. Possible side-effects of IDPN, points compared to changes in the biochemical indices such as progression of metabolic acidosis and frequent and total cell count. (Figure 1 ) Significant increases episodes of congestive heart failure or intradialysis hypotension were not observed in any patient. Neither in anthropometric indices were observed in patients Fig. 1 . Chronological data of anthropometric measurements during the entire experimental period. All values are expressed as mean and standard deviation (SD). At baseline, all values were higher in patients without intradialysis parenteral nutrition (IDPN ), although not significantly. Significant increases in these values were observed after 6 months in patients with IDPN($), whereas gradual decline of these values was observed in patients without IDPN (&). *P<0.05, **P<0.01 compared to baseline data. Abbreviations are the same as in Table 2 . Fig. 2 . Chronological data of other parameters during the entire experimental period. All values are expressed as mean and standard deviation (SD). No significant differences in all parameters between patients with and without intradialysis parenteral nutrition (IDPN ) were observed at baseline. After 3 months, marked increases in serum concentrations of albumin and transferrin and total lymphocyte count in peripheral blood film, as well as in dietary protein-calorie intake were observed in patients with IDPN ($), whereas these values gradually declined throughout the study period in patients without IDPN (&). *P<0.05, **P<0.01 compared to baseline data. Abbreviations are the same as in Table 2. with IDPN during the study period while significant pared to healthy subjects. In patients with IDPN, significant increases in plasma EAA and BCAA levels, reductions in these indices were observed in patients without IDPN.
leading to significant increases in the ratio of EAA to non-EAA and in the ratio of BCAA to total amino Amino-acid profiles in healthy subjects and the changes in the amino-acid profiles of the patients are acids were observed. A significant decrease in 3-methylhistidine was also observed. Significant further shown in Table 4 . At baseline, lower values of essential amino acids ( EAA) and branched-chain amino acids decreases in plasma EAA and BCAA levels and a persistent higher value of 3-methylhistidine were (BCAA) and a significantly higher value of 3-methylhistidine were observed in our patients com-observed in patients without IDPN. 
Discussion
counselling strongly suggests that IDPN plays a role in the correction of nutritional status. Direct infusion Among the many reported procedures for treating seems to promote a more effective utilization of nutrimalnutrition, such as oral amino-acids supplementents for protein synthesis and fat accumulation because ation, addition of nutrients to dialysate, hormonal of the multiple factors relating to uraemia and ageing supplementation (growth factors such as human adversely affecting the gastrointestinal system in nutrirecombinant growth hormone), and nutrient infusion tionally depleted elderly haemodialysis patients [11] . through a nasogastric feeding tube [19] [20] [21] [22] , we In this study, five patients without IDPN died during chose IDPN for our elderly patients. In recent the study period. IDPN seems to improve the mortality reports, IDPN containing essential amino acids, comrate in elderly haemodialysis patients, but statistical bined with either glucose or lipid emulsion, improved analysis could not be performed because of the small protein synthesis, anthropometric parameters, immunumber of patients and lack of randomized study nocompetence, spontaneous eating, quality of life, and groups. plasma amino-acid concentration in a general dialysis As a result of IDPN, the increase in spontaneous population [15] [16] [17] [18] . In a retrospective study, Capelli eating, also contributing to improved nutritional and co-workers showed that correction of hypoalbumistatus, may reflect an improvement in the general naemia by prolonged use of IDPN significantly reduced clinical condition of the patients. In a previous report, mortality rates in malnourished haemodialysis patients Skeie et al. stated that BCAA-enriched total parenteral (especially evident in non-diabetic patients) [17] . We nutrition stimulated oral food intake and appetite in also demonstrated an apparent improvement in nutrihealthy subjects and they speculated that anorexia tional status of elderly patients receiving IDPN, who observed in haemodialysis patients has been related to showed an improvement in visceral protein synthesis decreased levels of BCAA in plasma. [24] . A significant (especially albumin), anthropometric parameters, increase in plasma BCAA level in our patients receiving immunocompetence, and spontaneous oral intake, IDPN might contribute to the increase in spontaneous although our study groups were not completely ranoral intake. domized and a significant age difference between the The plasma amino-acid pattern, including BCAA, two groups existed. The failure of untreated patients to show significant improvement in either parameter was markedly improved in our patients receiving IDPN in contrast to previous observations, although values protein catabolism improved various indices of nutritional status and of immunocompetence in malnournever reached the control levels [11, 18] . We theorize that a concomitant increase in oral food intake in ished elderly patients without apparent side-effects.
Current evidence justifies use of IDPN in malnourished addition to prolonged intravenous administration of 42 g amino acids per week might be more effective in elderly haemodialysis patients as a feasible, effective method of nutrient supplementation. However, we correcting the depleted amino-acid pool in our elderly haemodialysis patients. In our patients the increases in cannot yet recommend IDPN as a routine therapy with regard to its cost-effectiveness and cannot propose amino acids resulted in significant increases in serum protein levels and muscle mass. In patients with the optimal composition of the nutrient regimen including vitamin supplementation. IDPN we demonstrated a significant reduction in 3-methylhistidine, a possible marker of muscle protein catabolism. This observation suggests a decreased cata-However, it is unclear whether reversal of protein-cal- thesis and fat accumulation and preventing muscle
